4 Firms Guide Up To $1.14B Sale Of PE-Backed Biotech
By Jade Martinez-Pogue · March 17, 2025, 12:53 PM EDT
Taiho Pharmaceuticals on Monday announced plans to acquire private equity-backed Swiss biotechnology company Araris Biotech for up to $1.14 billion in a deal built by four law firms....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login